Terms: = Liver cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659
15 results:
1. The Effect of the Histone Chaperones HSPA8 and dek on Tumor Immunity in Hepatocellular Carcinoma.
Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of antiviral therapy in patients with hepatitis B-related primary liver cancer.
Sun X; Yan X; Shao R; Pan F; Li T; Tian Q
J BUON; 2021; 26(3):897-903. PubMed ID: 34268951
[TBL] [Abstract] [Full Text] [Related]
3. [Construction of RNA interference (RNAi) lentiviral expression vector of dek gene and its effect on the biological behavior of liver cancer cells].
Li SH; Hou Y; Chen Z; Wu WR; Wu CX; Sun H
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):868-875. PubMed ID: 33105933
[No Abstract] [Full Text] [Related]
4. dek Is a Potential Biomarker Associated with Malignant Phenotype in Gastric cancer Tissues and Plasma.
Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
[TBL] [Abstract] [Full Text] [Related]
5. High expression of dek is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract] [Full Text] [Related]
6. Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.
Chen H; Gao F; He M; Ding XF; Wong AM; Sze SC; Yu AC; Sun T; Chan AW; Wang X; Wong N
Hepatology; 2019 Sep; 70(3):1011-1025. PubMed ID: 30637779
[TBL] [Abstract] [Full Text] [Related]
7. Does an extreme age (≥80 years) affect outcomes in patients after liver cancer surgery? A meta-analysis.
Wei F
ANZ J Surg; 2019 Jan; 89(1-2):25-31. PubMed ID: 29885205
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of dek expression by AP-2α and methylation level of dek promoter in hepatocellular carcinoma.
Qiao MX; Li C; Zhang AQ; Hou LL; Yang J; Hu HG
Oncol Rep; 2016 Oct; 36(4):2382-90. PubMed ID: 27499261
[TBL] [Abstract] [Full Text] [Related]
9. Critical role of dek and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-592 targets dek oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
Li X; Zhang W; Zhou L; Yue D; Su X
Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of dek gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract] [Full Text] [Related]
12. Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.
Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Mete M; Jonklaas J; Wartofsky L
Thyroid; 2012 Mar; 22(3):310-7. PubMed ID: 22313411
[TBL] [Abstract] [Full Text] [Related]
13. Proteomic analysis of proteins secreted by HepG2 cells treated with butyl benzyl phthalate.
Choi S; Park SY; Kwak D; Phark S; Lee M; Lim JY; Jung WW; Sul D
J Toxicol Environ Health A; 2010; 73(21-22):1570-85. PubMed ID: 20954082
[TBL] [Abstract] [Full Text] [Related]
14. Expression and significance of tumor-related genes in HCC.
Lü ZL; Luo DZ; Wen JM
World J Gastroenterol; 2005 Jul; 11(25):3850-4. PubMed ID: 15991281
[TBL] [Abstract] [Full Text] [Related]
15. Identification and characterization of genes associated with human hepatocellular carcinogenesis.
Kondoh N; Wakatsuki T; Ryo A; Hada A; Aihara T; Horiuchi S; Goseki N; Matsubara O; Takenaka K; Shichita M; Tanaka K; Shuda M; Yamamoto M
Cancer Res; 1999 Oct; 59(19):4990-6. PubMed ID: 10519413
[TBL] [Abstract] [Full Text] [Related]
